Delayed Expression of Circulating TGF-β1 and BMP-2 Levels in Human Nonunion Long Bone Fracture Healing

Abstract

Background:The healing process of bone fracture requires a well-controlled multistage and sequential order beginning immediately after the injury. However, complications leading to nonunion exist, creating serious problems and costs for patients. Transforming growth factor-beta 1 (TGF-β1) and bone morphogenic protein 2 (BMP-2) are two major growth factors involved in human bone fracture healing by promoting various stages of bone ossification. In this study, we aimed to determine the role of these factors during the fracture healing of human long bones and assess their impacts on nonunion condition. Materials and Methods:We performed a comprehensive analysis of plasma TGF-β1 and BMP-2 levels in blood samples from 10 patients with proved nonunion and 10 matched patients with normal union following a predetermined time schedule. The concentrations of TGF-β1 and BMP-2 were measured at each time point using a solid-phase ELISA.Results: TGF-β1 and BMP-2 levels were detectable in all patients. For all patients, a maximal peak for TGF-β1 was found at 3-week. In normal union group, TGF-β1 showed a maximal peak at 2-week while nonunion group had a delayed maximal peak at 3-week. Plasma levels of BMP-2 for all patients and for normal union group reached a maximal peak at 1-week, but nonunion group showed a delayed maximal peak at 2-week. In general, plasma TGF-β1 or BMP-2 level was not significantly different between normal union and nonunion groups. Conclusion:The expression levels of TGF-β1 and BMP-2 appeared to be delayed in nonunion patients which could play an important role in developing an early marker of fracture union condition and facilitate improved patient's management. (J Nippon Med Sch 2017; 84: 12 18)

Fracture Healing in Collagen-Related Preclinical Models of Osteogenesis Imperfecta

“…Although the role of TGFβ signaling has been well established as an inhibitor of chondrocyte differentiation in the growth plate, its effect is also known to be highly temporal and dosage dependent especially during fracture healing . In patients with delayed fracture healing, TGFβ1 levels were found to be significantly modulated at various time points throughout healing . Treatments of fractures with different TGFβ ligands administered in various ways have been shown to have highly variable results depending on dosage, timing, and whether treatment was localized or systemic .…”

Bone remodeling features in elderly and senile patients with the proximal femur fractures after hip replacement

“…This should be taken into account when evaluating the results, since our study included patients of old and old age with the presence of concomitant diseases. In a study by Hara Y. et al (2017) showed that in the group of patients with normal fracture of the fracture, the maximum peak of TGF-β1 was ob-served 2 weeks after the injury, and in the group without adhesion, a delayed maximum peak was observed after 3 weeks [5]. It is also possible that the very presence of an implant leads to a local release of TGF-β by osteoblasts.…”

Immune features of the bone remodelling after the hip arthroplasty in elderly and senile patients with proximal femur fractures

“…Як свідчать дослідження Y. Hara і співавт. [21], у групах пацієнтів із нормальним зрощенням перелому максимальну кількість TGF-β1 спостерігали через два тижні після травми, а серед пацієнтів без зрощення -через три. Також висловлено припущення, що власне наявність імплантата призводить до локального вивільнення TGF-β1 остеобластами [22].…”